Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1993 Feb;31(2):260–264. doi: 10.1128/jcm.31.2.260-264.1993

Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.

B D Roberts 1, S K Foung 1, J J Lipka 1, J E Kaplan 1, K G Hadlock 1, G R Reyes 1, L Chan 1, W Heneine 1, R F Khabbaz 1
PMCID: PMC262746  PMID: 8432811

Abstract

The confirmation of infection with human T-cell lymphotropic virus type I (HTLV-I) and type II (HTLV-II) currently involves multiple assays. These include Western blot (immunoblot) (WB) and/or radioimmunoprecipitation assay for detection of antibodies to HTLV-specific viral proteins and polymerase chain reaction and/or peptide-based enzyme immunoassays for differentiating between the two viruses. We undertook an evaluation of a modified WB assay that includes native HTLV-I viral proteins from MT-2 cells spiked with an HTLV-I transmembrane glycoprotein (recombinant p21e) and the HTLV-I- and HTLV-II-specific recombinant proteins MTA-1 and K55. The test panel consisted of well-characterized sera from U.S. blood donors, American Indians, intravenous drug users, and patients seen in sexually transmitted disease clinics. Of 158 HTLV-I/II-seropositive serum specimens tested, 156 (98.7%) were confirmed and typed as HTLV-I or HTLV-II. Of 82 HTLV-I/II-seroindeterminate or -seronegative serum specimens, only 1 was classified as HTLV-II positive: the sample had weak gag p19 and strong gag p24 and env p21e reactivity and was radioimmunoprecipitation assay negative for env gp61/68 but polymerase chain reaction positive for HTLV-II. The specificity of the modified WB for confirming and typing serum samples was therefore 100%. We conclude that this WB assay is useful for confirming and typing HTLV infection and can help simplify HTLV-I/II testing algorithms.

Full text

PDF
264

Images in this article

261Image
on p.261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cossen C., Hagens S., Fukuchi R., Forghani B., Gallo D., Ascher M. Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II. J Clin Microbiol. 1992 Mar;30(3):724–725. doi: 10.1128/jcm.30.3.724-725.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ehrlich G. D., Glaser J. B., LaVigne K., Quan D., Mildvan D., Sninsky J. J., Kwok S., Papsidero L., Poiesz B. J. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. Blood. 1989 Oct;74(5):1658–1664. [PubMed] [Google Scholar]
  3. Hartley T. M., Khabbaz R. F., Cannon R. O., Kaplan J. E., Lairmore M. D. Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol. 1990 Apr;28(4):646–650. doi: 10.1128/jcm.28.4.646-650.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hartley T. M., Malone G. E., Khabbaz R. F., Lal R. B., Kaplan J. E. Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms. J Clin Microbiol. 1991 Jun;29(6):1125–1127. doi: 10.1128/jcm.29.6.1125-1127.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Heneine W., Kaplan J. E., Gracia F., Lal R., Roberts B., Levine P. H., Reeves W. C. HTLV-II endemicity among Guaymi Indians in Panama. N Engl J Med. 1991 Feb 21;324(8):565–565. doi: 10.1056/NEJM199102213240815. [DOI] [PubMed] [Google Scholar]
  6. Hjelle B., Scalf R., Swenson S. High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. Blood. 1990 Aug 1;76(3):450–454. [PubMed] [Google Scholar]
  7. Khabbaz R. F., Heneine W., Grindon A., Hartley T. M., Shulman G., Kaplan J. Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II? J Acquir Immune Defic Syndr. 1992;5(4):400–404. [PubMed] [Google Scholar]
  8. Khabbaz R. F., Onorato I. M., Cannon R. O., Hartley T. M., Roberts B., Hosein B., Kaplan J. E. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 1992 Feb 6;326(6):375–380. doi: 10.1056/NEJM199202063260604. [DOI] [PubMed] [Google Scholar]
  9. Lairmore M. D., Jacobson S., Gracia F., De B. K., Castillo L., Larreategui M., Roberts B. D., Levine P. H., Blattner W. A., Kaplan J. E. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8840–8844. doi: 10.1073/pnas.87.22.8840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lal R. B., Brodine S., Kazura J., Mbidde-Katonga E., Yanagihara R., Roberts C. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections. J Clin Microbiol. 1992 Feb;30(2):296–299. doi: 10.1128/jcm.30.2.296-299.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lal R. B., Heneine W., Rudolph D. L., Present W. B., Hofhienz D., Hartley T. M., Khabbaz R. F., Kaplan J. E. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals. J Clin Microbiol. 1991 Oct;29(10):2253–2258. doi: 10.1128/jcm.29.10.2253-2258.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lipka J. J., Miyoshi I., Hadlock K. G., Reyes G. R., Chow T. P., Blattner W. A., Shaw G. M., Hanson C. V., Gallo D., Chan L. Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. J Infect Dis. 1992 Feb;165(2):268–272. doi: 10.1093/infdis/165.2.268. [DOI] [PubMed] [Google Scholar]
  13. Lipka J. J., Santiago P., Chan L., Reyes G. R., Samuel K. P., Blattner W. A., Shaw G. M., Hanson C. V., Sninsky J. J., Foung S. K. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II. J Infect Dis. 1991 Aug;164(2):400–403. doi: 10.1093/infdis/164.2.400. [DOI] [PubMed] [Google Scholar]
  14. Wiktor S. Z., Alexander S. S., Shaw G. M., Weiss S. H., Murphy E. L., Wilks R. J., Shortly V. J., Hanchard B., Blattner W. A. Distinguishing between HTLV-I and HTLV-II by western blot. Lancet. 1990 Jun 23;335(8704):1533–1533. doi: 10.1016/0140-6736(90)93078-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES